Meta-Analysis Is Not Appropriate for Burden of Disease Estimates

Published Jul 3, 2014
Brisbane, Australia - In burden of disease studies, decisions about the pooling of estimates, such as prevalence across countries, are largely made using conventional meta-analysis models. However, when there is true diversity and dissimilarity of effects, meta-analysis is not recommended. If the ultimate aim is to generate an average estimate of the disease measure across populations, there is a need to conduct sub-population-standardization, to account for differences in sub-population distribution within the populations from which primary disease measures are drawn. In the article “An Updated Method for Risk Adjustment in Outcomes Research,” published in Value in Health, researchers from theUniversity of Queensland in Brisbane describe how meta-analytic methods can be adapted to synthesize descriptive epidemiological data from different populations to arrive at pooled estimates for specific disease measures. In addition, internal and external standardization are distinguished for the first time. This approach enables a more accurate estimation of the standardized effect, and also simplifies the process of estimation of pooled measures to assess global or regional burden of disease. “Using meta-analytic methods in standardization makes it easier to carry out such pooled analyses of measures of incidence and prevalence, and this will lead to a more realistic reporting of the magnitude of global burden from different conditions, as well as differentials in disease burden across populations” said Suhail Doi, PhD who is from the University of Queensland. Having more realistic results will enhance decision making for intervention programs, for example, more equitable allocation of resources for such interventions.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×